THEMIS MEDICARE LTD. (THEMISMED) financials

THEMIS MEDICARE LTD. (THEMISMED) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Incorporated in 1969, Themis Medicare manufactures Formulation and API pharmaceutical products[1]

Market Cap: ₹981Cr.
Current Price: ₹107
ROE: -3.91%
ROCE: -0.46%
Book Value: ₹32.7
Dividend Yield: 0.47%
52W High / Low: ₹141/65.0

In Jun 2026, THEMIS MEDICARE LTD. (THEMISMED) reported sales ₹87 Cr and net profit ₹29 Cr.

Annual TTM: sales ₹332 Cr, net profit ₹30 Cr.

Shareholding: Promoters 67.10% (Jun 2026), FIIs 0.01% (Jun 2026), DIIs 0.01% (Jun 2026), Public 32.87% (Jun 2026), No. of Shareholders 21,267% (Jun 2026).

THEMISMED quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	117	94	72	98	78	90	77	87
Expenses	100	85	77	108	81	80	73	139
Operating Profit	17	9	-6	-10	-3	10	4	-52
OPM %	15%	9%	-8%	-10%	-4.0%	11%	4.9%	-60%
Other Income	1	1	2	-0	3	0	4	101
Interest	2	3	2	2	3	3	3	3
Depreciation	2	3	3	3	3	3	3	3
Profit before tax	13	4	-9	-15	-5	5	2	43
Tax %	26%	27%	-16%	1%	3%	6%	8%	33%
Net Profit	10	3	-8	-15	-5	5	2	29
EPS in Rs	1.07	0.33	-0.84	-1.67	-0.58	0.50	0.21	3.12
Raw PDF	—	—	—	—	—	—	—	—

THEMISMED profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	202	231	395	354	382	406	342	332
Expenses	166	181	299	287	330	356	343	374
Operating Profit	36	50	96	67	52	49	-1	-42
OPM %	18%	22%	24%	19%	14%	12%	-0.3%	-13%
Other Income	3	4	7	12	5	5	8	108
Interest	13	13	9	10	9	10	11	11
Depreciation	8	9	9	10	12	10	10	10
Profit before tax	18	32	84	59	35	34	-13	45
Tax %	12%	17%	27%	26%	29%	29%	6%	—
Net Profit	16	27	62	43	25	24	-14	30
EPS in Rs	1.73	2.90	6.69	4.71	2.69	2.60	-1.54	3.25
Dividend Payout %	10%	15%	7%	11%	19%	19%	-32%	—

THEMISMED balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	9	9	9	9	9	9	9	9
Reserves	134	150	177	234	273	292	311	292
Borrowings	82	100	87	80	92	96	83	100
Other Liabilities	74	67	65	61	82	93	102	99
Total Liabilities	299	326	338	384	456	490	506	500
Fixed Assets	123	116	133	144	162	168	172	167
CWIP	2	8	2	3	3	3	3	2
Investments	11	11	11	11	11	11	11	11
Other Assets	162	191	192	226	280	308	320	320
Total Assets	299	326	338	384	456	490	506	500

THEMISMED cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	11	0	57	34	16	22	35	-3
Cash from Investing Activity	-4	-5	-16	-16	-24	-16	-12	-3
Cash from Financing Activity	-10	7	-26	-18	0	-9	-26	4
Net Cash Flow	-3	2	16	1	-8	-3	-3	-2
Free Cash Flow	5	-5	39	15	-13	4	21	-8
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	439%	2%	114%	55%	48%	60%	93%	-356%

THEMISMED shareholding pattern (%)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoters	67.15%	67.15%	67.15%	67.15%	67.15%	67.10%	67.10%	67.10%
FIIs	0.10%	0.10%	0.14%	0.09%	0.06%	0.05%	0.11%	0.01%
DIIs	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%
Public	32.74%	32.75%	32.70%	32.75%	32.77%	32.84%	32.78%	32.87%
No. of Shareholders	14,270	17,773	17,889	19,335	22,490	22,576	21,818	21,267

THEMISMED key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	145	186	123	93	150	170	160	190
Inventory Days	284	313	273	150	213	188	233	229
Days Payable	186	171	144	79	123	126	142	143
Cash Conversion Cycle	243	328	253	165	239	233	251	275
Working Capital Days	1	38	54	74	111	117	123	138
ROCE %	-1%	13%	17%	31%	20%	11%	11%	-0%

THEMISMEDUpdated 18 Oct 2026, 5:02

Themis Medicare Ltd.

THEMISMEDUpdated 18 Oct 2026, 5:02

Market Cap

₹981Cr.

Current Price

₹107

High / Low

₹141/65.0

ROE-3.91%

ROCE-0.46%

Book Value₹32.7

Face Value₹1.00

Dividend Yield0.47%

About

Incorporated in 1969, Themis Medicare manufactures Formulation and API pharmaceutical products[1]

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	69	2	58	6	1	15	16	13	1.37
Sep 2023	105	2	92	2	3	10	27	7	0.77
Dec 2023	83	3	74	1	3	3	30	2	0.22
Mar 2024	76	2	67	0	1	6	45	3	0.34
Jun 2024	123	2	94	1	2	25	26	19	2.03
Sep 2024	117	2	100	1	2	13	26	10	1.07
Dec 2024	94	3	85	1	3	4	27	3	0.33
Mar 2025	72	2	77	2	3	-9	-16	-8	-0.84
Jun 2025	98	2	108	0	3	-15	1	-15	-1.67
Sep 2025	78	3	81	3	3	-5	3	-5	-0.58
Dec 2025	90	3	80	0	3	5	6	5	0.5
Mar 2026	77	3	73	4	3	2	8	2	0.21
Jun 2026	87	3	139	101	3	43	33	29	3.12

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2015	167	14	156	12	7	2	-30	2	0.24
Mar 2016	203	12	171	3	7	15	-4	15	1.77
Mar 2017	217	12	184	3	7	16	10	15	1.64
Mar 2018	210	12	184	3	7	9	1	9	1.01
Mar 2019	184	12	182	3	8	-15	-13	-13	-1.38
Mar 2020	202	13	166	3	8	18	12	16	1.73
Mar 2021	231	13	181	4	9	32	17	27	2.9
Mar 2022	395	9	299	7	9	84	27	62	6.69
Mar 2023	354	10	287	12	10	59	26	43	4.71
Mar 2024	382	9	330	5	12	35	29	25	2.69
Mar 2025	406	10	356	5	10	34	29	24	2.6
Mar 2026	342	11	343	8	10	-13	6	-14	-1.54
TTM	332	11	374	108	10	45	—	30	3.25

Shareholding pattern

As of Jun 2026%

Holder	Share
Promoters	67.1%
FIIs	0.01%
DIIs	0.01%
Public	32.87%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Public
Sep 2023	67.16%	0.05%	0.01%	32.77%
Dec 2023	67.16%	0.01%	0.01%	32.82%
Mar 2024	67.15%	0.03%	0.01%	32.81%
Jun 2024	67.15%	0.05%	0.01%	32.79%
Sep 2024	67.15%	0.1%	0.01%	32.74%
Dec 2024	67.15%	0.1%	0.01%	32.75%
Mar 2025	67.15%	0.14%	0.01%	32.7%
Jun 2025	67.15%	0.09%	0.01%	32.75%
Sep 2025	67.15%	0.06%	0.01%	32.77%
Dec 2025	67.1%	0.05%	0.01%	32.84%
Mar 2026	67.1%	0.11%	0.01%	32.78%
Jun 2026	67.1%	0.01%	0.01%	32.87%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2015	8	40	109	67	225	92	3	11	119	225
Mar 2016	9	56	95	61	220	89	5	11	115	220
Mar 2017	9	133	82	54	278	124	9	12	133	278
Mar 2018	9	147	80	56	292	126	2	11	153	292
Mar 2019	9	134	82	74	299	123	2	11	162	299
Mar 2020	9	150	100	67	326	116	8	11	191	326
Mar 2021	9	177	87	65	338	133	2	11	192	338
Mar 2022	9	234	80	61	384	144	3	11	226	384
Mar 2023	9	273	92	82	456	162	3	11	280	456
Mar 2024	9	292	96	93	490	168	3	11	308	490
Mar 2025	9	311	83	102	506	172	3	11	320	506
Mar 2026	9	292	100	99	500	167	2	11	320	500

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2015	11	-2	-15	-6
Mar 2016	19	-4	-13	2
Mar 2017	-2	-4	5	0
Mar 2018	8	0	-9	-1
Mar 2019	11	-4	-10	-3
Mar 2020	0	-5	7	2
Mar 2021	57	-16	-26	16
Mar 2022	34	-16	-18	1
Mar 2023	16	-24	0	-8
Mar 2024	22	-16	-9	-3
Mar 2025	35	-12	-26	-3
Mar 2026	-3	-3	4	-2

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	88	73	81	120	145	186	123	93	150	170	160	190
Inventory Days	223	210	250	253	284	313	273	150	213	188	233	229
Days Payable	272	152	163	156	186	171	144	79	123	126	142	143
Cash Conversion Cycle	38	131	168	217	243	328	253	165	239	233	251	275
Working Capital Days	-50	-40	-16	21	1	38	54	74	111	117	123	138
ROCE %	10%	17%	15%	9%	-1%	13%	17%	31%	20%	11%	11%	-0%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of THEMIS MEDICARE LTD. (THEMISMED)?

The reported market capitalisation for THEMIS MEDICARE LTD. (THEMISMED) is ₹981Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of THEMISMED?

The current price shown for THEMIS MEDICARE LTD. (THEMISMED) on Fincrux is ₹107 with a 52-week high/low of ₹141/65.0.

What were THEMISMED latest quarterly results?

For Jun 2026, THEMIS MEDICARE LTD. (THEMISMED) reported sales ₹87 Cr and net profit ₹29 Cr (figures in ₹ crore unless noted).

What are THEMISMED annual sales and net profit?

For TTM, THEMIS MEDICARE LTD. (THEMISMED) shows sales of ₹332 Cr and net profit of ₹30 Cr on the Fincrux profit & loss statement.

Who owns THEMIS MEDICARE LTD. (THEMISMED)?

Latest shareholding for THEMIS MEDICARE LTD. (THEMISMED) on Fincrux: Promoters 67.10% (Jun 2026), FIIs 0.01% (Jun 2026), DIIs 0.01% (Jun 2026), Public 32.87% (Jun 2026), No. of Shareholders 21,267% (Jun 2026).

Where can I find THEMIS MEDICARE LTD. (THEMISMED) financials?

THEMIS MEDICARE LTD. (THEMISMED) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show THEMISMED balance sheet and cash flow?

Yes. The THEMIS MEDICARE LTD. (THEMISMED) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 18 October 2026 at 5:02